BryanNBeckerMDMMM, FACP, CPE
Nephrology • Fort Worth, TXKidney & Pancreas Transplantation
National Medical Director, VillageMD
Dr. Becker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4904 Bellaire Dr S
Fort Worth, TX 76109
Education & Training
Vanderbilt University Medical CenterFellowship, Nephrology, 1992 - 1995
Duke University HospitalFellowship, Nephrology, 1991 - 1992- Duke University HospitalResidency, Internal Medicine, 1988 - 1991
University of Kansas School of MedicineClass of 1988
Certifications & Licensure
IL State Medical License 2010 - 2026
TX State Medical License 2022 - 2026
WI State Medical License 1997 - 2021
NC State Medical License 1990 - 2011
TN State Medical License 1993 - 2004- American Board of Internal Medicine Nephrology
Clinical Trials
- Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- 189 citationsReassessing the Cardiac Risk Profile in Chronic Hemodialysis Patients: A Hypothesis on the Role of Oxidant Stress and Other Non-Traditional Cardiac Risk FactorsBryan N. Becker, Jonathan Himmelfarb, William L. Henrich, Raymond M. Hakim
Journal of the American Society of Nephrology. 1997-03-01 - 97 citationsPlasma F2-isoprostane levels are elevated in chronic hemodialysis patients.Talat Alp Ikizler, Jason D. Morrow, L. J. Roberts, James Evanson, Bryan N. Becker
Clinical Nephrology. 2002-09-01 - 177 citationsRenal disease and hypertension in non–insulin-dependent diabetes mellitusNuhad Ismail, Bryan N. Becker, Piotr Strzelczyk, Eberhard Ritz
Kidney International. 1999-01-01
Journal Articles
- Association of Chronic Condition Special Needs Plan with Hospitalization and Mortality Among Patients with End-Stage Kidney DiseaseBryan N Becker, Steven M Brunelli, JAMA Network Open
Press Mentions
Chutes & Ladders—Vanderbilt Names New CMO; Boston Children's Taps Lead for PediatricsFebruary 17th, 2023- VillageMD Welcomes Bryan Becker, M.D., as National Medical DirectorFebruary 7th, 2023
- Security Pros Must Keep up with Growth in TelehealthJuly 27th, 2020
- Join now to see all
Grant Support
- Angiotensin II Receptor Blockade And Chronic RejectionNational Center For Research Resources2004–2006
- Clinical Translational Research In Transplant NephrologyNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
- Intrarenal Oxygenation And Oxidant Stress In Patients With CKD And CanNational Center For Research Resources2004
- E M Transdifferentiation In Proximal Tubule CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Angiotensin II Receptor Blockade And Chronic RejectionNational Institute Of Allergy And Infectious Diseases2000–2003
- MAP Kinase In The Evolution Of GlomerulosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000
- Properties Of Proximal Tubule Angiotensin II ReceptorsNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1999
- Properties Of Proximal Tubule Angiotensin II ReceptorsNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
Professional Memberships
- Member
- Member
- Fellow
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
